1039.6000 4.00 (0.39%)
NSE Sep 10, 2025 15:31 PM
Volume: 1.1M
 

logo
Zydus Lifesciences Ltd.
10 Feb 2020, 12:00AM
1039.60
0.39%
ICICI Securities Limited
Q3FY20 revenues grew 1.7% YoY to | 3638.1 crore (I-direct estimate: | 3439.7 crore). Consolidation of Craft Portfolio was largely offset by 13.4% YoY decline in the US to | 1675.3 crore. Domestic formulations grew 7.6% YoY to | 910.3 crore. EBITDA margins contracted 441 bps YoY to 19.1% (Idirect estimate: 18.8%), mainly on account of higher employee and other expenditure. EBITDA de-grew 17.4% YoY to | 693.2 crore (I-direct estimate: | 646.7 crore). PAT de-grew 26.5% YoY to | 375.2 crore (I-direct estimates:...
Zydus Lifesciences L.. has an average target of 1045.33 from 6 brokers.
More from Zydus Lifesciences Ltd.
Recommended